Insmed, Inc. (INSM) Social Stream
INSMED Inc (INSM) Price Targets From Analysts
Use the tables below to see what analysts covering INSMED Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 41 weeks, INSM's average price target has gone down $3.01.
Over the past 46 weeks, INSM's average upside potential has been 92.99%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
INSM Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 123 days, INSM's average broker recommendation rating improved by 0.32.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how INSMED Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 801.01% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, INSMED Inc's variance in analysts' estimates is lower than -163.64% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, INSMED Inc's number of analysts covering the stock is greater than 704.74% of them.
- INSMED Inc's average analyst price target is greater than 692.31% of Pharmaceutical Products stocks.
Make investment decisions regarding INSM using the data that counts. Try POWR Ratings for free.